Programming note: No Curve tomorrow. Back Monday. Behave, y’all. We’re in the thick of earnings season, and we had quarterly numbers drop today from Sanofi, AstraZeneca, AbbVie, and Roche. All

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.

Programming note: Cost Curve is off tomorrow, back Monday. There are a couple of overlapping milestones this week.  First off, Monday was the deadline by which CMS was supposed to

It’s been a big week for commercials mocking PBMs as smug, suit-wearing jerks. Here’s PhRMA’s latest, positing that insurance companies are the same smug jerk as the PBMs, only with

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.

Tomorrow morning, UnitedHealth Group will report earnings. I’m no Gordon Gekko, but you can put good money on UHG’s Optum unit delivering record-setting profits, driven in part by its OptumRx

It’s a quiet summer Friday, and I’m going to take advantage of the slow news flow to spend a little extra time on one of my favorite activities: handicapping future

I didn’t realize, when I woke up on Monday morning, that this would be PBM Week — a close cousin to Shark Week — but here we are.  There’s a